Any thoughts on COVID-19 impact for this business in the US markets in the last few months? It's one of the key risk been highlighted in the prospectus.
The latest annual report was for the period ended 31 March 2020. A lot has happened in the US between Mar and Aug, the management team should have a clear view now in terms of the financial impact on HY ended 30 Sep 2020.
Any thoughts on COVID-19 impact for this business in the US...
-
- There are more pages in this discussion • 437 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ARX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
-0.010(1.79%) |
Mkt cap ! $189.6M | |||
| Open | High | Low | Value | Volume |
| 56.3¢ | 56.5¢ | 55.0¢ | $35.93K | 64.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94399 | 55.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 62182 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| ARX (ASX) Chart |